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Background: Innate immunity utilizes components of sensory signal transduction such as bitter and sweet taste
receptors. In fact, empirical evidence has shown bitter and sweet taste receptors to be an integral component of
antimicrobial immune response in upper respiratory tract infections. Since an efficient immune response plays a key
role in the attainment of longevity, it is not surprising that the rs978739 polymorphism of the bitter taste receptor
TAS2R16 gene has been shown to be associated with longevity in a population of 941 individuals ranging in age from
20 to 106 years from Calabria (Italy). There are many possible candidate genes for human longevity, however of the
many genes tested, only APOE and FOXO3 survived to association in replication studies. So, it is necessary to validate in
other studies genes proposed to be associated with longevity. Thus, we analysed the association of the quoted
polymorphism in a population of long lived individuals (LLIs) and controls from another Italian population from Cilento.
Methods: The analysis has been performed on data previously obtained with genome-wide association study on a
population of LLIs (age range 90–109 years) and young controls (age range 18–45 years) from Cilento (Italy).
Results: Statistical power calculations showed that the analysed cohort represented by 410 LLIs and 553 young
controls was sufficiently powered to replicate the association between rs978739 and the longevity phenotype
according to the effect size and frequencies described in the previous paper, under a dominant and additive genetic
model. However, no evidence of association between rs978739 and the longevity phenotype was observed according
to the additive or dominant model.
Conclusion: There are several reasons for the failure of the confirmation of a previous study. However, the differences
between the two studies in terms of environment of the population adopted and of the criteria of inclusion have
made difficult the replication of the findings.
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Senses can be defined as systems that consist of groups of
sensory cells responding to specific physical phenomenon
and corresponding to particular brain regions where the
received signals are interpreted. In humans, classically, we
consider five senses, hearing, smell, sight, taste, touch.
Concerning taste sense, humans are able to discriminate
five tastes through tongue receptors: sweet, umami, sour,
salty, and bitter, which are referred as the basic tastes. Taste
perception plays a key role in food preference, dietary* Correspondence: calogero.caruso@unipa.it
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that taste receptors are also expressed in a myriad of other
tissues, from the airway and gastrointestinal epithelia to
the pancreas and brain, where they participate in a variety
of biological processes. Growing evidence suggests that
genetic variants of taste receptors play a role in disease
aetiology, serving as modifying factors [1, 2].
The immune system and nervous system communicate
with one another using a common chemical language.
Thus, immune system is considered as our ‘sixth sense’ by
informing the nervous system about the presence of path-
ogens, allergens and cancer cells that the body cannot
otherwise hear, see, smell, taste or touch. They com-
municate via a complete bidirectional circuit sharingle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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neuroendocrine hormones and cytokines [3, 4].
Considering the above statement, it is intriguing that
several mechanisms of innate immunity utilize compo-
nents of sensory signal transduction such as bitter and
sweet taste receptors. In fact, empirical evidence has
shown bitter and sweet taste receptors to be an integral
component of antimicrobial immune response in upper
respiratory tract infections. In fact, they have recently been
shown to be sentinels of defence against infection in the
airway, where they function as a novel arm of innate im-
munity, as described in detail by Lee and Cohen [5].
Emerging evidence also supports the hypothesis that taste
receptors serve similar immune roles in at least some of
the other tissues in which they are expressed [6].
Because of the role of an efficient immune response in
the attainment of longevity [7, 8], it is not surprising that
some polymorphism of the bitter taste receptor genes i.e.
taste receptor, type 2, member 16, 4 and 5 (TAS2R16,
TAS2R4 and TAS2R5 respectively) has been shown to be
associated with longevity in a population of 941 individ-
uals ranging in age from 20 to 106 years from Calabria
(Italy). After correction for multiple testing only one single
nucleotide polymorphism (SNP), rs978739, showed a sta-
tistically significant association with longevity (p = 0.001).
In particular, the frequency of homozygotes A/A increased
gradually from 35% in the subjects aged 20 to 70 up to
55% in centenarians [9].
Exceptional long living individuals (LLIs), i.e. people be-
longing to the 5 percentile of the survival curve, are genet-
ically predisposed to reach extreme ages. There are many
possible candidate genes for human longevity, however of
the many genes tested, only APOE and FOXO3 survived
to association in replication studies. So, it is necessary to
validate in other studies genes proposed to be associated
with longevity [10, 11].
Therefore, in the present paper, to validate this datum,
we analysed the association of the previous quoted SNP in
a population of LLIs and controls from another Italian
population i.e. Southern Italian Centenarian Study (SICS)
form Cilento [12, 13].Table 1 Results from association tests. ID = dbSNP ID; m =
minor allele; M = Major allele; MAF =minor allele frequency;
Model = genetic model tested; OR (95% CI) = Odds Ratio and
95% Confidence Interval; p = p-value
ID m M MAF Model OR (95% CI) P
rs978739 G A 0.32 Additive
(per copy of G)
0.92 (0.76–1.12) 0.427
GA vs. AA 1.09 (0.83–1.43)
GG vs. AA 0.69 (0.43–1.10)
Dominant
(GG/GA vs. AA)
1.01 (0.78–1.30) 0.955Results and discussion
Statistical power calculations showed that the analysed
cohort represented by 410 LLIs and 553 young controls
[13] was sufficiently powered (1 – β ≥ 0.85) to replicate
the association between rs978739 and the longevity
phenotype according to the effect size and frequencies
described in Campa et al., [9], under a dominant and
additive genetic model. The statistical power to replicate
the association of rs6466849, rs860170, rs2233998 and
rs2227264 was extremely low (1 – β < 0.80) [9] therefore
they were not analysed.The imputed SNP rs978739 (Minor Allele = G with
Minor Allele Frequency (MAF) = 0.32) did not signifi-
cantly deviate from the Hardy Weinberg Equilibrium
(HWE) in the control population (p = 0.63), was charac-
terized by no missing values (0%) and had an average
maximum posterior call of 0.999.
No evidence of association between rs978739 and the
longevity phenotype was observed according to the
additive (odd ratio (OR) per copy of the G allele = 0.92,
95% CI = 0.76–1.12, p = 0.427) or dominant model (OR
GG/GA vs. AA = 1.01, 95% CI = 0.78–1.30, p – value =
0.955) (Table 1).
Theoretically, there are several reasons for the failure of
the confirmation of a previous study [14, 15]. They include
the followings. 1) The lack of statistical power either in the
discovery or in the replication set. In fact, a result should
be supported by an adequate number of study participants,
calculated on the number of hypothesis tested and on the
frequency of the genetic variant analysed. Indeed, more
hypothesises and rare variants require larger populations
that one hypothesis and a common variant. If we consider
that many studies are unpublished if negative, the thresh-
old of significance should take multiple testing into ac-
count even if only one test is published. It is possible that
in the previous finding [9], statistics do not consider this
multiple testing issue generating a false positive result. 2)
The generation of false positives due to the population
stratification. In fact, if we compare cases with controls
that are not balanced in terms of genetic background, the
observed skewing is probably due to the differences in fre-
quency unrelated to the phenotype but depending on the
genetic background, the so called genetic admixture. The
paradigmatic example is that coming from a study of the
association between a GM haplotype and non-insulin-
dependent diabetes mellitus on Pima Indians. This study
showed an association of the haplotype that disappeared
when analysis was restricted to full-heritage Indians [16].
The population adopted by the present study has been
controlled for genetic admixture through genetic com-
ponent analysis and exclusion of outliers [13]. 3) The
differences in adopted criteria for inclusion among studies
(age of cases and controls, the familiar component of their
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analysed populations that could count for different demo-
graphic pressures. Indeed, there is an open discussion on
the opportunity to replicate the data using populations
belonging to the same area. On the other hand, if an asso-
ciation is replicated in heterogeneous populations the re-
sults can be generalized to entire community.
Conclusion
The differences between the two studies in terms of en-
vironment of the population adopted and of the criteria
of inclusion have made difficult the replication of the
findings.
Methods
The analysis has been performed on data previously ob-
tained with genome-wide association study (GWAS) on
a population of LLIs (age range 90–109 years) and young
controls (age range 18–45 years). They had been recruited
as part of the SICS. The LLIs were thoroughly investigated
for demographic characteristics, medical history (past and
present diseases), level of independence and cognitive sta-
tus. All subjects donated blood samples for DNA study
and gave written informed consent to the study, which
was approved by Ethical Committee of Multimedica Hos-
pital. All methods were performed in accordance with the
relevant guidelines and regulations. The study was con-
ducted in accordance with the ethical principles that have
their origin in the Declaration of Helsinki.
Genotyping had been carried out with the Infinium II
Assay-HumanHap BeadChip 317 K duo system (Illu-
mina, San Diego, California) using standard protocols of
the Illumina HumanHap 317 Duo workflow (Illumina,
San Diego, CA). All genotypes had been evaluated using
a quantitative quality score called GenCall score. The
initial screening dataset was represented by 466 LLIs
and 624 controls. After quality control, it was looked for
evidence of genetic population stratification on a subset
of 454 LLIs and 591 young controls. After outliers were
removed (n = 82), the final GWAS dataset was composed
of 963 samples, of which 410 were cases (age range, 90–
109 years; male/female ratio, 1.4, and 553 were controls
(age range, 18–48 years; male/female ratio, 1.56).
Statistical power calculations were performed by the
Quanto software (http://biostats.usc.edu/Quanto.html) based
on results described in Campa et al. [9] except for
the sample size of the replication cohort [13]. The
significance threshold was set to α = 0.05.
Concerning imputation of unobserved genotypes, pre-
phasing was performed by the SHAPEIT2 software [17]
increasing the number of states up to 500 in order to
improve the phasing accuracy and using the reference
genetic map for chromosome 7, where TAS2R16 gene is
located [9]. The deriving haplotypes were then used asinput during the imputation of unobserved genotypes
that was performed by the Impute2 software [18].
The SNPTEST software tool was used to test for asso-
ciation between SNP and the longevity phenotype using
the score method under the dominant and additive gen-
etic models and to test for statistically significant devia-
tions from the HWE.
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